Table 4.

Clinical epidemiology of hypertension in NHANES 2007–2008 vs. 2009–2010: Impact of untreated twice-told hypertensive patients with non-hypertensive BP.

NHANES		2007–2008	2009–2010	P-value
Def A	Number	2057	2093
Prevalence, %		29.0 (27.6, 30.5)	28.4 (26.3, 30.6)	0.32
Awareness, %		80.7 (78.2, 83.0)	81.1 (78.1, 83.8)	0.41
Treated,%		72.7 (70.3, 74.9)	75.8 (72.0, 79.2)	0.06
Controlled, %	<140/<90	50.1 (46.8, 53.5)	53.3 (50.3, 56.3)	0.07
<140/<90, <130/<80 DM/CKD†		44.7 (41.0, 48.4)	48.4 (45.3, 51.4)	0.05
Def B	Number	2221	2284
Prevalence, %		32.2 (30.8, 33.7)	31.4 (29.3, 33.6)	0.32
Awareness, %		82.6 (80.1, 84.9)	83.0 (80.2, 85.5)	0.41
Treated, %		65.5 (63.4, 67.6)	68.6 (65.2, 71.8)	0.06
Controlled, %	<140/<90	55.0 (51.4, 58.6)	57.8 (54.8, 60.8)	0.07
<140/<90, <130/<80 DM/CKD†		49.8 (45.9, 53.7)	53.2 (50.2, 56.2)	0.05

Def=Definition; A=excluding and B=including untreated, twice-told hypertensive with non-hypertensive BP (ntHTN). DM=diabetes mellitus; CKD=chronic kidney disease

^†Hypertension control with BP goal <140<90 in patients without and <130/<80 mmHg in patients with diabetes mellitus and/or chronic kidney disease